AU2019325656B2 - Thyroid hormone receptor beta agonist compounds - Google Patents
Thyroid hormone receptor beta agonist compounds Download PDFInfo
- Publication number
- AU2019325656B2 AU2019325656B2 AU2019325656A AU2019325656A AU2019325656B2 AU 2019325656 B2 AU2019325656 B2 AU 2019325656B2 AU 2019325656 A AU2019325656 A AU 2019325656A AU 2019325656 A AU2019325656 A AU 2019325656A AU 2019325656 B2 AU2019325656 B2 AU 2019325656B2
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- compound
- oxo
- methyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2025206402A AU2025206402A1 (en) | 2018-08-24 | 2025-07-22 | Thyroid hormone receptor beta agonist compounds |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862722312P | 2018-08-24 | 2018-08-24 | |
| US62/722,312 | 2018-08-24 | ||
| US201962867117P | 2019-06-26 | 2019-06-26 | |
| US62/867,117 | 2019-06-26 | ||
| PCT/US2019/047968 WO2020041741A1 (en) | 2018-08-24 | 2019-08-23 | Thyroid hormone receptor beta agonist compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2025206402A Division AU2025206402A1 (en) | 2018-08-24 | 2025-07-22 | Thyroid hormone receptor beta agonist compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2019325656A1 AU2019325656A1 (en) | 2021-03-11 |
| AU2019325656B2 true AU2019325656B2 (en) | 2025-04-24 |
Family
ID=69584321
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019325656A Active AU2019325656B2 (en) | 2018-08-24 | 2019-08-23 | Thyroid hormone receptor beta agonist compounds |
| AU2025206402A Pending AU2025206402A1 (en) | 2018-08-24 | 2025-07-22 | Thyroid hormone receptor beta agonist compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2025206402A Pending AU2025206402A1 (en) | 2018-08-24 | 2025-07-22 | Thyroid hormone receptor beta agonist compounds |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10800767B2 (enExample) |
| EP (1) | EP3840755A4 (enExample) |
| JP (2) | JP7579253B2 (enExample) |
| CN (1) | CN112805005A (enExample) |
| AU (2) | AU2019325656B2 (enExample) |
| CA (1) | CA3110520A1 (enExample) |
| MA (1) | MA53448A (enExample) |
| TW (1) | TWI837169B (enExample) |
| WO (1) | WO2020041741A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI884745B (zh) | 2018-10-12 | 2025-05-21 | 美商拓臻股份有限公司 | 甲狀腺素受體β促效劑化合物 |
| CN111320609A (zh) | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| FI3965884T3 (fi) | 2019-05-08 | 2025-04-02 | Aligos Therapeutics Inc | Thr-beetan modulaattoreita, joissa on diokso-1,2,4-triatsyylipääryhmä |
| WO2020228577A1 (zh) * | 2019-05-10 | 2020-11-19 | 深圳微芯生物科技股份有限公司 | 一种哒嗪酮衍生物及其应用 |
| US12398127B2 (en) | 2019-09-12 | 2025-08-26 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CN114437034A (zh) * | 2020-11-06 | 2022-05-06 | 深圳微芯生物科技股份有限公司 | 一种酞嗪类化合物的可药用盐、晶型及其制备方法 |
| AU2021377248A1 (en) | 2020-11-13 | 2023-06-22 | Inipharm, Inc. | Dichlorophenol hsd17b13 inhibitors and uses thereof |
| CN114621207B (zh) * | 2020-12-11 | 2025-02-11 | 广东东阳光药业股份有限公司 | 一种作为甲状腺激素β受体激动剂的化合物及其用途 |
| EP4301357A4 (en) * | 2021-03-03 | 2025-01-22 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CN117624073A (zh) * | 2021-03-19 | 2024-03-01 | 南京明德新药研发有限公司 | 双环苯酚类化合物及其应用 |
| CN117624154A (zh) * | 2021-03-19 | 2024-03-01 | 南京明德新药研发有限公司 | 双环吡啶酮类化合物及其应用 |
| EP4568664A1 (en) | 2023-04-07 | 2025-06-18 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating a liver disorder or a cardiometabolic disease |
| CN116554063B (zh) * | 2023-05-23 | 2025-03-07 | 江苏省农用激素工程技术研究中心有限公司 | 氟胺磺隆中间体的制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007009913A1 (en) * | 2005-07-21 | 2007-01-25 | F. Hoffmann-La Roche Ag | Pyridazinone derivatives as thyroid hormone receptor agonists |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7230031B2 (en) * | 2002-01-30 | 2007-06-12 | Kissei Pharmaceutical Co., Ltd. | Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| US7572799B2 (en) * | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| GB0327319D0 (en) * | 2003-11-24 | 2003-12-24 | Pfizer Ltd | Novel pharmaceuticals |
| WO2007132475A1 (en) * | 2006-05-15 | 2007-11-22 | Cadila Healthcare Limited | Selective tr-beta 1 agonist |
| WO2008130637A1 (en) * | 2007-04-18 | 2008-10-30 | New York University | Hydrazide compounds as thyroid hormone receptor modulators and uses thereof |
| EP3725779A4 (en) | 2018-01-23 | 2021-02-24 | Shenzhen TargetRx, Inc. | SUBSTITUTED PYRIDAZINONE COMPOUND |
| CN113683597A (zh) | 2018-06-12 | 2021-11-23 | 四川海思科制药有限公司 | 甲状腺激素受体激动剂及其用途 |
| EP3864013A4 (en) | 2018-10-12 | 2022-09-28 | InventisBio Co., Ltd. | Thyroid hormone receptor agonists |
-
2019
- 2019-08-23 US US16/549,979 patent/US10800767B2/en active Active
- 2019-08-23 JP JP2021533405A patent/JP7579253B2/ja active Active
- 2019-08-23 AU AU2019325656A patent/AU2019325656B2/en active Active
- 2019-08-23 MA MA053448A patent/MA53448A/fr unknown
- 2019-08-23 EP EP19852050.4A patent/EP3840755A4/en active Pending
- 2019-08-23 WO PCT/US2019/047968 patent/WO2020041741A1/en not_active Ceased
- 2019-08-23 CA CA3110520A patent/CA3110520A1/en active Pending
- 2019-08-23 TW TW108130298A patent/TWI837169B/zh active
- 2019-08-23 CN CN201980066702.0A patent/CN112805005A/zh active Pending
-
2024
- 2024-08-29 US US18/818,705 patent/US20250236615A1/en active Pending
- 2024-10-25 JP JP2024187991A patent/JP2025020206A/ja active Pending
-
2025
- 2025-07-22 AU AU2025206402A patent/AU2025206402A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007009913A1 (en) * | 2005-07-21 | 2007-01-25 | F. Hoffmann-La Roche Ag | Pyridazinone derivatives as thyroid hormone receptor agonists |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7579253B2 (ja) | 2024-11-07 |
| AU2025206402A1 (en) | 2025-08-07 |
| TW202023560A (zh) | 2020-07-01 |
| US20250236615A1 (en) | 2025-07-24 |
| CA3110520A1 (en) | 2020-02-27 |
| MA53448A (fr) | 2022-04-20 |
| EP3840755A1 (en) | 2021-06-30 |
| US20200062742A1 (en) | 2020-02-27 |
| CN112805005A (zh) | 2021-05-14 |
| US10800767B2 (en) | 2020-10-13 |
| EP3840755A4 (en) | 2022-04-20 |
| JP2025020206A (ja) | 2025-02-12 |
| TWI837169B (zh) | 2024-04-01 |
| WO2020041741A1 (en) | 2020-02-27 |
| JP2021535207A (ja) | 2021-12-16 |
| AU2019325656A1 (en) | 2021-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019325656B2 (en) | Thyroid hormone receptor beta agonist compounds | |
| JP2023011933A (ja) | アリール置換またはヘテロアリール置換ベンゼン化合物 | |
| CN115038448B (zh) | 调节蛋白质募集和/或降解的化合物 | |
| JP2022110080A (ja) | Ｅｈｍｔ２阻害剤としてのアミン置換複素環化合物およびその使用方法 | |
| US11203587B2 (en) | Thyroid hormone receptor beta agonist compounds | |
| BR112020001124A2 (pt) | composto ou o sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso do composto ou do sal farmaceuticamente aceitável do mesmo e método para tratamento de câncer | |
| KR20200139676A (ko) | 아미노산 화합물 및 사용 방법 | |
| BR112014007721B1 (pt) | Processos para preparar compostos úteis como inibidores de atr quinase | |
| RU2633694C2 (ru) | Дейтерированный фениламинопиримидин и фармацевтическая композиция, содержащая такое соединение | |
| AU2018353122B2 (en) | Amine-substituted heterocyclic compounds as EHMT2 inhibitors, salts thereof, and methods of synthesis thereof | |
| AU2020346057A1 (en) | Thyroid hormone receptor beta agonist compounds | |
| US20220274961A1 (en) | Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors | |
| TW201103894A (en) | 4-substituted pyridazinone compound and p2x7 receptor inhibitor | |
| AU2021256157A1 (en) | Tricyclic compounds as EGFR inhibitors | |
| US11447470B2 (en) | Pyrimidinone-containing compound, preparation method thereof, pharmaceutical composition and application thereof | |
| JP2022532520A (ja) | 癌を処置するための化合物 | |
| TW201000470A (en) | Diaryl compounds and uses thereof | |
| WO2019200267A1 (en) | Tricyclic ask1 inhibitors | |
| TW201026691A (en) | Biaryl spiroaminooxazoline analogues as alpha2C adrenergic receptor modulators | |
| BR112020006185B1 (pt) | Compostos ou sais farmaceuticamente aceitáveis dos mesmos e uso dos mesmos | |
| BR112020006185A2 (pt) | derivado de anel fundido utilizado como inibidor de receptor a2a | |
| JPH05271230A (ja) | ジアザビシクロ誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |